Shanghai Rongtai Health Technology Corporation Limited (SHA:603579)

SHA:603579 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	174.95	150.7	191.95	202.71	164.23	236.34
Depreciation & Amortization	53.9	53.61	57.01	59.96	58.92	62.78
Other Amortization	10.06	8.34	3.36	9.78	14.69	6.18
Loss (Gain) From Sale of Assets	-0.99	-1.73	-0.7	0.95	-0.15	-1.31
Asset Writedown & Restructuring Costs	-5.83	3.1	1.21	1.29	0.01	1.7
Loss (Gain) From Sale of Investments	-131.45	-107.04	-37.54	-20.5	-34.6	-99.5
Provision & Write-off of Bad Debts	-0.1	-0.1	1.13	-1.3	30.49	56.6
Other Operating Activities	21.81	26.54	11.39	33.63	14.58	44.59
Change in Accounts Receivable	-108.31	8	-10.43	-114.93	115.61	-115.66
Change in Inventory	-59.2	-5.63	-10.84	55.03	71.05	-33.3
Change in Accounts Payable	131.74	31.8	-43.23	118.5	-198.77	178.44
Change in Other Net Operating Assets	2.01	2.89	1.95	10.62	7.44	-11.09
Operating Cash Flow	83.21	174.77	168.14	344.29	236.79	337.92
Operating Cash Flow Growth	-72.38%	3.94%	-51.16%	45.40%	-29.93%	22.61%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-88.62	-111.86	-151.08	-89.61	-100.65	-141.46
Sale of Property, Plant & Equipment	3.38	3.67	1.96	2.81	4.38	7.7
Cash Acquisitions	-13.07	-	-	-	-	-
Divestitures	-	-	-	-	-	-8.16
Investment in Securities	223.65	327.46	-1,026	207.57	-128.78	88.61
Other Investing Activities	-561.61	-	2.49	0.19	-	-11.99
Investing Cash Flow	-436.27	219.27	-1,173	120.96	-225.04	-65.3

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	361.07	425.79	-	543.76	114.77
Long-Term Debt Issued	-	-	-	149.13	-	-
Total Debt Issued	601.76	361.07	425.79	149.13	543.76	114.77
Short-Term Debt Repaid	-	-621.09	-129.13	-	-249.5	-
Long-Term Debt Repaid	-	-	-	-429.02	-1.12	-4.28
Total Debt Repaid	-383.18	-621.09	-129.13	-429.02	-250.62	-4.28
Net Debt Issued (Repaid)	218.58	-260.02	296.66	-279.89	293.14	110.49
Issuance of Common Stock	-	-	22.97	-	-	80.42
Repurchase of Common Stock	-	-	-	-50.01	-	-100.05
Common Dividends Paid	-100.22	-61.93	-199.82	-78.06	-103.59	-72.25
Other Financing Activities	-32.83	2.71	0.76	-18.21	-1.95	-44.82
Financing Cash Flow	85.53	-319.24	120.57	-426.17	187.59	-26.22

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-11.4	-1.82	3.7	10	21.19	-17.2
Net Cash Flow	-278.93	72.99	-880.09	49.09	220.53	229.19

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	-5.41	62.91	17.06	254.69	136.14	196.45
Free Cash Flow Growth	-	268.75%	-93.30%	87.08%	-30.70%	129.87%
Free Cash Flow Margin	-0.31%	4.00%	1.07%	13.73%	6.79%	7.52%
Free Cash Flow Per Share	-0.03	0.35	0.09	1.47	0.78	1.08
Levered Free Cash Flow	-333.22	-19.42	-1.59	92.24	-25.02	35.84
Unlevered Free Cash Flow	-320.46	-6.66	2.1	109.37	-7.03	53.8

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	-	11.98	-30.42	27.21	-49.67	-72.46
Change in Working Capital	-39.13	41.35	-59.67	57.79	-11.38	30.54

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error